ARK Genomic Revolution ETF (ARKG) is a Financial Services etf trading at $45.53 (as of 2026-09-11), with a market capitalization of $1.27B. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
| Price | $45.53 |
| Market Cap | $1.27B |
| Sector P/E (Financial Services) | 6.7 |
| Industry P/E (Asset Management) | 7.1 |
| Top Institutional Holder | MORGAN STANLEY ($508.13M) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 1 |
| Sector | Financial Services |
| Industry | Asset Management |
| Country | US |
| IPO Date | 2014-10-31 |
Data as of 2026-09-11.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.